Two Sigma Securities’s Epizyme, Inc EPZM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-44,420
Closed -$65K 3302
2022
Q2
$65K Buy
+44,420
New +$32.6K ﹤0.01% 1816

Other funds holding EPZM

Two Sigma Securities's EPZM Position: Q3 2022 in Review

Two Sigma Securities sold out of Epizyme, Inc (EPZM) in Q3 2022, closing a stake of 44,420 shares — an estimated $65K sold.

Two Sigma Securities first reported a position in EPZM in Q2 2022 and held it in 1 quarter. The position peaked at $65K in Q2 2022. 0 funds tracked by Wall St. Rank hold EPZM as of Q3 2022.

  • Two Sigma Securities reported no remaining Epizyme, Inc position as of Q3 2022 after selling out during the quarter.
  • Two Sigma Securities sold 44,420 Epizyme, Inc shares in Q3 2022, an estimated $65K.
  • Two Sigma Securities first reported a position in Epizyme, Inc in Q2 2022 and held it in 1 quarter.
  • Two Sigma Securities's Epizyme, Inc position peaked at $65K in Q2 2022.
  • 0 funds tracked by Wall St. Rank held Epizyme, Inc as of Q3 2022.

Based on Two Sigma Securities's 13F filing for Q3 2022, filed 14 Nov 2022.